The end of production at one of pharmaceutical firm GlaxoSmithKline's (GSK) UK factories is a "sad day", a former worker has ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...

Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

The presented data provides a snapshot of the financial health and recent market performance of key stocks within the NIFTY MIDCAP 150 index.

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.

U.S. Senator Maggie Hassan has initiated an investigation into GlaxoSmithKline's decision to discontinue the Flovent HFA ...

Senator Maggie Hassan launches an investigation into GlaxoSmithKline's withdrawal of a popular asthma inhaler, linking it to ...

The global vitamin D therapy market was valued at approximately USD 4.59 billion in 2022 and is projected to grow at an impressive growth rate of around 11.6% over the forecast period from 2023 to ...